Biora Therapeutics Inc (BIOR) Key Ratios

$0.69

up-down-arrow $0.00 (0.01%)

As on 08-Jul-2022 09:30EDT

Market cap

info icon

$163 Mln

Revenue (TTM)

info icon

$1 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -2.80 -77.54 -98.47 -78.64 --
EBIT 75.48 94.59 24.02 -136.02 --
Net Profit 60.07 92.98 33.19 -56.27 --
EPS -- -- 61.86 -- --
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-21Dec-20
EBIT-Margin info -6,398.79---15,251.46-18,836.81-262.66
Net Margin info 68.89--376.16527.31-389.54
Return on equity info 234.84----257.76201.74
Return on Capital info 532.74----3,501.69-645.88
Return on Assets info -158.00---90.97-187.95-150.31
Debt to Equity (x) info -----1.32---1.66
ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Biora Therapeutics Inc (BIOR)
--
3,501.69
-645.88
-1,257.59
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

--

--

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Biora Therapeutics Inc (BIOR)
--
257.76
201.74
245.01
--
Peer Median
-26.31
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-90.97

Lower than Peers by 78.01

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Biora Therapeutics Inc (BIOR)
-90.97
-187.95
-150.31
-135.74
--
Peer Median
-12.96
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-15,251.46

Lower than Peers by 15,191.76

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Biora Therapeutics Inc (BIOR)
-15,251.46
-18,836.81
-262.66
-96.92
-89.68
Peer Median
-59.70
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

376.16

Higher than Peers by 447.22

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Biora Therapeutics Inc (BIOR)
376.16
527.31
-389.54
-102.81
-100.88
Peer Median
-71.06
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

-0.02

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Biora Therapeutics Inc (BIOR)
-0.02
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Revenue Growth

-98.47

Lower than Peers by 119.03

Year on year growth in net sales

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Biora Therapeutics Inc (BIOR)
-98.47
-0.98
-0.48
0.13
--
Peer Median
20.56
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

24.02

Higher than Peers by 8.82

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Biora Therapeutics Inc (BIOR)
24.02
-20.34
-39.88
-21.59
--
Peer Median
15.20
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

33.19

Higher than Peers by 25.32

Year on year growth in profit after tax

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Biora Therapeutics Inc (BIOR)
33.19
-28.51
-30.05
-14.66
--
Peer Median
7.86
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

--

--

Year on year growth in earnings per share

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Biora Therapeutics Inc (BIOR)
--
0.62
0.07
--
--
Peer Median
30.45
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Debt to Equity

-1.32

--

Total debt / Net worth

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Biora Therapeutics Inc (BIOR)
-1.32
--
-1.66
-0.87
-1.94
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

-0.06

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Biora Therapeutics Inc (BIOR)
-0.06
-0.22
-0.01
0.00
-0.01
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

1.48

Lower than Peers by 2.00

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Biora Therapeutics Inc (BIOR)
1.48
1.60
1.74
0.74
1.14
Peer Median
3.48
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

1.48

Lower than Peers by 1.81

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Biora Therapeutics Inc (BIOR)
1.48
--
1.57
0.63
1.04
Peer Median
3.29
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-10.33

Lower than Peers by 8.82

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Biora Therapeutics Inc (BIOR)
-10.33
--
--
--
--
Peer Median
-1.51
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

82.11

Higher than Peers by 57.78

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Biora Therapeutics Inc (BIOR)
82.11
52.37
17.07
15.85
6.37
Peer Median
24.33
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.01

Lower than Peers by 0.22

Sales / Average Total Assets

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Biora Therapeutics Inc (BIOR)
0.01
0.01
0.58
1.32
--
Peer Median
0.23
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Biora Therapeutics Inc (BIOR)
--
1,952.93
87.25
39.28
23.25
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Biora Therapeutics Inc (BIOR)
--
--
45.26
33.72
30.21
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Biora Therapeutics Inc (BIOR)
--
--
64.82
48.68
43.77
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Biora Therapeutics Inc (BIOR)
--
--
67.69
24.31
9.69
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Biora Therapeutics Inc (BIOR)
--
-1.40
-1.36
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

--

--

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Biora Therapeutics Inc (BIOR)
--
-4.08
-2.45
--
--
Peer Median
4.96
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Biora Therapeutics Inc (BIOR)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

--

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Biora Therapeutics Inc (BIOR)
--
-1.11
-1.83
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

163

Higher than Peers by 80

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Biora Therapeutics Inc (BIOR)
163
--
--
--
--
Peer Median
83
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...